WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (LMDX), a next-generation point of care diagnostics company, today announced findings from its second annual “Point of Care ...
The global point-of-care testing (POCT) market is driven by rising patient demand, technological innovation, and supportive regulatory frameworks. Rapid diagnostics, enhanced chronic disease ...
Point of care testing in the emergency department: Finding comprehensive solutions that work for you
Speed and precision are two of the most vital considerations when it comes to patient care in the high-stakes environment of the Emergency Department (ED). Thus, swift decision-making and accurate ...
Large scale deployment of rapid, low-cost, hand-held point of care testing devices for diagnosing infectious diseases is critical for improving global health. Recent advances in engineering and ...
This presentation will briefly cover point-of-care testing (POCT) from a historical standpoint. (What are we doing and why did we decide to do it this way?) This presentation will incorporate ...
Point-of-care testing in community pharmacies is becoming more common, according to a new report by the International Pharmaceutical Federation, which also cited challenges that remain to be addressed ...
Every second counts in the Intensive Care Unit (ICU), with changes in patient status potentially occurring quickly and with no prior warning. Around-the-clock blood testing capabilities are essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback